L1 cell adhesion molecule is a novel therapeutic target in intrahepatic cholangiocarcinoma

Clinical Cancer Research

Volumn 16, Issue 14, 2010, Pages 3571-3580

  Min, Jeong Ki ^a   Kim, Jin Man ^b   Li, Shengjin ^b   Lee, Jung Whoi ^a   Yoon, Hyunho ^a   Ryu, Chun Jeih ^a,h   Jeon, Soung Hoo ^a   Lee, Jae Hyek ^e   Kim, Jin Young ^c   Yoon, Hee Kwan ^a   Lee, Young Kwan ^a   Kim, Bong Hui ^a   Son, Yeon Sung ^a   Choi, Hong Seo ^a   Lim, Nam Kyu ^d   Kim, Dae Ghon ^f   Hong, Hyo Jeong ^g  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Chungnam National University   (South Korea)

^c Korea Basic Science Institute (KBSI)   (South Korea)

^d Aprogen Inc   (South Korea)

^e Chonnam National University Medical School   (South Korea)

^f Chonbuk National University Medical School   (South Korea)

^g Kangwon National University   (South Korea)

^h Sejong University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GEMCITABINE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY A10 A3; NERVE CELL ADHESION MOLECULE L1; NERVE CELL ADHESION MOLECULE L1 ANTIBODY; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN BINDING; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BILE DUCT CARCINOMA; CANCER GROWTH; CANCER INHIBITION; CELL INVASION; CELL MEMBRANE; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG TARGETING; EPITHELIUM; EXPERIMENTAL NEOPLASM; FEMALE; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; LIVER CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR XENOGRAFT;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGEN-ANTIBODY REACTIONS; APOPTOSIS; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; BLOTTING, WESTERN; CELL MOVEMENT; CELL PROLIFERATION; CHOLANGIOCARCINOMA; DISEASE PROGRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; NEURAL CELL ADHESION MOLECULE L1; TUMOR CELLS, CULTURED;

EID: 77954711918     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-09-3075     Document Type: Article

References (46)

1. Patel T. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology 2001;33:1353-57. (Pubitemid 32496970)
2. Taylor-Robinson SD, Toledano MB, Arora S, et al. Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998. Gut 2001;48:816-20.
3. Khan SA, Taylor-Robinson SD, Toledano MB, Beck A, Elliot P, Thomas HC. Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J Hepatol 2002;37:43-57.
4. Khan SA, Thomas HC, Davidson BR, Taylor RS. Cholangiocarcinoma. Lancet 2005;366:1303-14.
5. Washburn WK, Lewis WD, Jenkins RL. Aggressive surgical resection for cholangiocarcinoma. Arch Surg 1995;130:270-6.
6. Ohtsuka M, Ito H, Kimura F, et al. Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival. Br J Surg 2002;89:1525-31. (Pubitemid 35404319)
7. Brummendorf T, Rathjen FG. Axonal glycoproteins with immunoglobulin- and fibronectin type III-related domains in vertebrates: structural features, binding activities, and signal transduction. J Neurochem 1993;61:1207-19. (Pubitemid 23285076)
8. Hortsch M. The L1 family of neural cell adhesion molecules: old proteins performing new tricks. Neuron 1996;17:587-93. (Pubitemid 26365339)
9. Lindner J, Rathjen FG, Schachner M. L1 mono- and polyclonal antibodies modify cell migration in early postnatal mouse cerebellum. Nature 1983;305:427-30. (Pubitemid 14225148)
10. Miura M, Asou H, Uyemura K. The cell adhesion molecule L1 has a specific role in neural cell migration. J Biol Chem 1992;267:10752-58.
11. Dahme M, Bartsch U, Martini R, Anliker B, Schachner M, Mantei N. Disruption of the mouse L1 gene leads to malformations of the nervous system. Nat Genet 1997;17:346-49. (Pubitemid 27476003)
12. Demyanenko GP, Tsai AY, Maness PF. Abnormalities in neuronal process extension, hippocampal development, and the ventricular system of L1 knockout mice. J Neurosci 1999;19:4907-20.
13. Thor G, Probstmeier R, Schachner M. Characterization of the cell adhesion molecules L1, N-CAM and J1 in the mouse intestine. EMBO J 1987;6:2581-86.
14. Ebeling O, Duczmal A, Aigner S, et al. L1 adhesion molecule on human lymphocytes and monocytes: expression and involvement in binding to αvβ3 integrin. Eur J Immunol 1996:262508-16.
15. Pancook JD, Reisfeld RA, Varki N, Vitiello A, Fox RI, Montgomery AMP. Expression and regulation of the neural cell adhesion molecule L1 on human cells of myelomonocytic and lymphoid origin. J Immunol 1997;158:4413-21. (Pubitemid 127483945)
16. Debiec H, Christensen EI, Ronco PM. The cell adhesion molecule L1 is developmentally regulated in the renal epithelium and is involved in kidney branching morphogenesis. J Cell Biol 1998;143:2067-79. (Pubitemid 29022625)
17. Nolte C, Moos M, Schachner M. Immunolocalization of the neural cell adhesion molecule L1 in epithelia of rodents. Cell Tissue Res 1999;298:261-73. (Pubitemid 29512078)
18. Izumoto S, Ohnishi T, Arita N, Hiraga S, Taki T, Hayakawa T. Gene expression of neural cell adhesion molecule L1 in malignant gliomas and biological significance of L1 in glioma invasion. Cancer Res 1996;56:1440-4. (Pubitemid 26080991)
19. Hoefnagel CA, Rutgers M, Buitenhuis CK, et al. A comparison of targeting of neuroblastoma with mIGB and anti L1-CAM antibody mAb chCE7: therapeutic efficacy in a neuroblastoma patients. Eur J Nucl Med 2001;28:359-68.
20. Thies A, Schachner M, Moll I, et al. Overexpression of the cell adhesion molecule L1 is associated with metastasis in cutaneous malignant melanoma. Eur J Cancer 2002;38:1708-16.
21. Allory Y, Matsuoka Y, Bazille C, Christensen EI, Ronco P, Debiec H. The L1 cell adhesion molecule is induced in renal cancer cells and correlates with metastasis in clear cell carcinomas. Clin Cancer Res 2005;11:1190-7. (Pubitemid 40175770)
22. Gavert N, Conacci-Sorrel M, Gast D, et al. L1, a novel target of β-catenin signaling, transforms cells and is expressed at the invasive front of colon cancer. J Cell Biol 2005;168:633-42. (Pubitemid 40271028)
23. Haspel J, Grumet M. The L1CAM extracellular region: multi-domain protein with modular and cooperative binding modes. Front Biosci 2003;8:1210-25.
24. Gast D, Riedle S, Schabath H, et al. L1 augments cell migration and tumor growth but not β3 integrin expression in ovarian carcinomas. Int J Cancer 2005;115:658-65.
25. Voura EB, Ramjeesingh RA, Montgomery AM, Siu CH. Involvement of integrin α(v)β(3) and cell adhesion molecule L1 in transendothelial migration of melanoma cells. Mol Biol Cell 2001;12:2699-710.
26. 3-mediated migration of human tumor cells and activated T lymphocytes. Biochem Biophys Res Commun 1997;232:236-9.
27. Silletti S, Yebra M, Perez B, Cirulli V, McMahon M, Montgomery AM. Extracellular signal-regulated kinase (ERK)-dependent gene expression contributes to L1 cell adhesion molecule-dependent motility and invasion. J Biol Chem 2004;279:28880-8. (Pubitemid 38915755)
28. Mechtersheimer S, Gutwein P, Agmon-Levin N, et al. Ectodomain shedding of L1 adhesion molecule promotes cell migration by autocrine binding to integrins. J Cell Biol 2001;155:661-73.
29. Nayeem N, Silletti S, Yang X, et al. A potential role for the plasmin (ogen) system in the posttranslational cleavage of the neural cell adhesion molecule L1. J Cell Sci 1999;112:4739-49. (Pubitemid 30034821)
30. Gutwein P, Mechtersheimer S, Riedle S, et al. ADAM10-mediated cleavage of L1 adhesion molecule at the cell surface and in released membrane vesicles. FASEB J 2003;17:292-4.
31. Primiano T, Baig M, Maliyekkel A, et al. Identification of potential anticancer drug targets through the selection of growth-inhibitory genetic suppressor elements. Cancer Cell 2003;4:41-53. (Pubitemid 36904160)
32. Arlt MJE, Novak-Hofer I, Gast D, et al. Efficient inhibition of intraperitoneal tumor growth and dissemination of human ovarian carcinoma cells in nude mice by anti-L1-cell adhesion molecule monoclonal antibody treatment. Cancer Res 2006;66:936-43. (Pubitemid 43165961)
33. Bao S, Wu Q, Li Z, et al. Targeting cancer stem cells through L1CAM suppresses gliomas growth. Cancer Res 2008;68:6043-8.
34. Kim DG, Park SY, You KR, et al. Establishment and characterization of chromosomal aberrations in human cholangiocarcinoma cell lines by cross-species color banding. Genes Chromosomes Cancer 2001;30:48-56.
35. Son YS, Park JH, Kang YK, et al. Heat shock 70 kDa protein 8 isoform 1 is expressed on the surface of human embryonic stem cells and downregulated upon differentiation. Stem Cells 2005;23:1502-13.
36. Tamada S, Shibahara H, Higashi M, et al. MUC4 is a novel prognostic factor of extrahepatic bile duct carcinoma. Clin Cancer Res 2006;12:4257-64.
37. Min JK, Kim JH, Cho YL, et al. 20(S)-Ginsenoside Rg3 prevents endothelial cell apoptosis via inhibition of a mitochondrial caspase pathway. Biochem Biophys Res Commun 2006;349:987-94.
38. Guo W, Giancotti FG. Integrin signaling during tumor progression. Nat Rev Mol Cell Biol 2004;10:816-26.
39. Vivanco I, Sawyers CL. The phosphatidylinositol 3-kinase-AKT pathway in human cancer. Nat Rev Cancer 2002;2:489-501. (Pubitemid 37328931)
40. Takeda Y, Asou H, Murakami Y, et al. A nonneuronal isoform of cell adhesion molecule L1: tissue-specific expression and functional analysis. J Neurochem 1996;66:2338-49. (Pubitemid 26159068)
41. Thongprasert S. The role of chemotherapy in cholangiocarcinoma. Ann Oncol 2005;16:ii93-6.
42. Stoeck A, Gast D, Sanderson MP, Issa Y, Gutwein P, Altevogt P. L1-CAM in a membrane-bound or soluble form augments protection from apoptosis in ovarian carcinoma cells. Gynecol Oncol 2007;104:461-9. (Pubitemid 46156956)
43. Zecchini S, Bianchi M, Colombo N, et al. The differential role of L1 in ovarian carcinoma and normal ovarian surface epithelium. Cancer Res 2008;68:1110-18. (Pubitemid 351272229)
44. Weidle UH, Eggle DA, Klostermann S. L1-CAM as a target for treatment of cancer with monoclonal antibodies. Anticancer Res 2009;29:4919-32.
45. Knogler K, Grünberg J, Zimmermann K, et al. Copper-67 radioimmunotherapy and growth inhibition by anti-L1-cell adhesion molecule monoclonal antibodies in a therapy model of ovarian cancer metastasis. Clin Cancer Res 2007;13:603-11. (Pubitemid 46225367)
46. Huszar M, Moldenhauer G, Gschwend V, et al. Expression profile analysis in multiple human tumors identifies L1 (CD171) as a molecular marker for differentiated diagnosis and targeted therapy. Hum Pathol 2006;37:1000-8. (Pubitemid 44097029)